Balance Training in Diabetic Neuropathy
Launched by DOW UNIVERSITY OF HEALTH SCIENCES · Jan 15, 2020
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age group: 30-60 years
- • Diabetes type II patients diagnosed with peripheral neuropathy by medical doctor for at least 5 years
- • Neuropathy present (on the basis of Michigan Neuropathy Screening Instrument
- • Have balance impairment ( evaluation on Berg Balance Scale)
- Exclusion Criteria:
- • Neuropathy due to other medical conditions like Vitamin deficiency, Hypothyroidism, Auto-immune/ demyelinating diseases
- • Foot ulcers
- • Lower limb amputee
- • Vestibular diseases
- • Retinopathy
- • Cardiac problems
- • Hemiplegia/ Stroke
About Dow University Of Health Sciences
Dow University of Health Sciences (DUHS) is a premier educational and research institution based in Karachi, Pakistan, dedicated to advancing healthcare through innovative research and clinical excellence. As a clinical trial sponsor, DUHS integrates cutting-edge scientific inquiry with practical applications, fostering a collaborative environment that promotes the development of new treatments and therapies. The institution is committed to upholding the highest ethical standards in research, ensuring participant safety, and contributing to the global body of medical knowledge. With a focus on interdisciplinary collaboration and community health impact, DUHS plays a pivotal role in enhancing the quality of healthcare both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials